AYRMID

Serial Number 99283009
686

Registration Progress

Application Filed
Jul 14, 2025
Under Examination
Approved for Publication
Jan 6, 2026
Published for Opposition
Jan 6, 2026
Registered

Attorney Assistance

Published for Opposition
Due: Feb 05, 2026 7 days

Trademark Image

AYRMID

Basic Information

Serial Number
99283009
Filing Date
July 14, 2025
Published for Opposition
January 6, 2026
Drawing Code
4

Status Summary

Current Status
Active
Status Code
686
Status Date
Jan 6, 2026
Application
Pending
Classes
005

Rights Holder

Ayrmid Pharma Ltd

99
Address
88 Harcourt Street
Dublin 2
Dublin D02 DK18
IE

Ownership History

Ayrmid Pharma Ltd

Original Applicant
99
Dublin IE

Ayrmid Pharma Ltd

Owner at Publication
99
Dublin IE

Legal Representation

Attorney
Charles T.J. Weigell

USPTO Deadlines

Next Deadline
7 days remaining
Published for Opposition
Due Date
February 05, 2026
Extension Available
Until March 05, 2026

Application History

12 events
Date Code Type Description Documents
Jan 6, 2026 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Jan 6, 2026 PUBO A PUBLISHED FOR OPPOSITION Loading...
Dec 31, 2025 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Dec 10, 2025 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Dec 10, 2025 XAEC I EXAMINER'S AMENDMENT ENTERED Loading...
Dec 10, 2025 GNEN O NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED Loading...
Dec 10, 2025 GNEA F EXAMINERS AMENDMENT E-MAILED Loading...
Dec 10, 2025 CNEA R EXAMINERS AMENDMENT -WRITTEN Loading...
Dec 2, 2025 DOCK D ASSIGNED TO EXAMINER Loading...
Jul 14, 2025 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Jul 14, 2025 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Jul 14, 2025 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations for the treatment of cancer; pharmaceutical preparations for the treatment of hematological diseases; pharmaceutical preparations used in hematopoietic transplants; allogenic cell therapy preparations for the prevention and treatment of cancer; pharmaceutical preparations for use in hematology and in tissue and organ transplantation

Classification

International Classes
005